Butalbital-acetaminophen-caffeine (BAC) contains three active ingredients that each address pain differently. It’s considered a controlled substance due to the risk of dependency and potential for ...

WALL, S.D. and ATLANTA, March 17, 2022 /PRNewswire/ -- Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. today announced the launch of Butalbital, Acetaminophen and Caffeine Capsules USP, ...

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

Lannett has received the Food and Drug Administration’s clearance for butalbital, acetaminophen and caffeine, or BAC, capsules in two dosage strengths. The two dosage strengths of BAC capsules — 50 mg ...

PHILADELPHIA, Dec. 23, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New ...

Patients seeking relief of the symptom complex of tension (or muscle contraction) headache will soon have a new generic treatment. Strides Pharma has received the Food and Drug Administration’s ...

Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets, USP 50mg/325mg/40mg and Four Lots of Hydrocodone Bitartrate ...

Mutual Pharmaceutical has received FDA approval of its Abbreviated New Drug Application (ANDA) for Butalbital 50mg/Acetaminophen 325mg/Caffeine 40mg tablets. Mutual's Butalbital 50mg/Acetaminophen ...

Lannett Company, Inc. ( LCI) recently announced that the US Food and Drug Administration (FDA) granted approval to the company's abbreviated new drug application (ANDA) for its generic version of ...

June 27, 2011 — Qualitest Pharmaceuticals is voluntarily withdrawing generic pain-relief tablets combining hydrocodone bitartrate and acetaminophen (Vicodin), as well as another generic combining ...

The label includes a Boxed Warning describing the risk of hepatotoxicity associated with APAP. Most cases of liver injury were associated with APAP doses >4000mg daily and often involved >1 ...